EPOC y calidad de vida relacionada con la salud: Una revisión narrativa
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | Vera Brand, Julieta | |
| dc.contributor.author | Ahumada Sánchez, Cruz María | |
| dc.contributor.author | Hernández Flores, Luisa Fernanda | |
| dc.contributor.author | Ruiz Campillo, Aura Vanessa | |
| dc.date.accessioned | 2020-10-25T11:57:46Z | |
| dc.date.available | 2020-10-25T11:57:46Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | La enfermedad pulmonar obstructiva crónica (EPOC) es una enfermedad con amplias implicaciones sociales y económicas en los países, se espera que su incidencia mundial siga aumentando, siendo para la próxima década la cuarta causa de muerte en el mundo. El deterioro físico subsecuente a la disfunción pulmonar trae consigo una serie de cambios multisistémicos que desencadenan la reducción de la capacidad funcional del individuo, dichos fenómenos están relacionados con la severidad de los síntomas y también el detrimento del sistema cardiovascular y musculoesquelético. Por ende, los pacientes con EPOC tienden a reducir su calidad de vida relacionada con la salud (CVRS) y consigo, una reducción de la expectativa de vida. El tratamiento del paciente con esta enfermedad no se limita a la farmacoterapia y tratamientos paliativos secundarios, sino que también trasciende en la identificación de la magnitud de factores que afectan la CVRS y una intervención sobre estos. La presente revisión tuvo el objetivo de explorar, analizar y exponer evidencia científica más reciente que asocia a la funcionalidad y calidad de vida relacionada con la salud en pacientes con EPOC. Los principales hallazgos muestran la importancia de evaluar e intervenir los factores que reducen la CVRS. Alternativas como la educación y coaching en salud parecen ser alternativas que, en cierta medida, logran reducir el impacto de la enfermedad en diversas esferas del individuo. | spa |
| dc.description.abstract | Chronic obstructive pulmonary disease (COPD) is a disease with broad social and economic implications in the countries, it is expected that its worldwide incidence will continue to increase, being for the next decade the fourth cause of death in the world. The physical deterioration subsequent to pulmonary dysfunction brings with it a series of multisystemic changes that trigger the reduction of the functional capacity of the individual, these phenomena are related to the severity of the symptoms and also the detriment of the cardiovascular and musculoskeletal system. Therefore, patients with COPD tend to reduce their health-related quality of life (HRQoL) and with it, a reduction in life expectancy. Treatment of patients with this disease is not limited to pharmacotherapy and secondary palliative treatments, but also transcends the identification of the magnitude of factors that affect HRQOL and an intervention on these. The present review aimed to explore, analyze, and present the most recent scientific evidence associated with functionality and health-related quality of life in patients with COPD. The main findings show the importance of evaluating and intervening the factors that reduce HRQL. Alternatives such as health education and coaching seem to be alternatives that, to a certain extent, manage to reduce the impact of the disease in various spheres of the individual. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/6734 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | eng |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Calidad de vida | spa |
| dc.subject | Calidad de vida relacionada con la salud | spa |
| dc.subject | Disnea | spa |
| dc.subject | Autocuidado | spa |
| dc.subject | Enfermedad pulmonar obstructiva crónica | spa |
| dc.subject | Chronic obstructive pulmonary disease | spa |
| dc.subject | Quality of life | eng |
| dc.subject | Health-related quality of life | eng |
| dc.subject | Dyspnoea | eng |
| dc.subject | Self Care | eng |
| dc.title | EPOC y calidad de vida relacionada con la salud: Una revisión narrativa | spa |
| dc.title.translated | COPD and health-related quality of life: A narrative review | eng |
| dc.type.driver | info:eu-repo/semantics/other | eng |
| dc.type.spa | Otros | spa |
| dcterms.references | Halpin D, Celli B, Criner G, Frith P, López M, Salvi S, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019; 23(11): 1131-41. | eng |
| dcterms.references | GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691-706. | eng |
| dcterms.references | Singh D, Agusti A, Anzueto A, Barnes P, Bourbeau J, Bartolome R, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019; 53(5): 1900164. | eng |
| dcterms.references | Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007; 370: 741-50. | eng |
| dcterms.references | Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren L, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971-985. | eng |
| dcterms.references | Ntritsos G, Franek J, Belbasis L, Christou M, Markozannes G, Altman P, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018, 10(13): 1507-14. | eng |
| dcterms.references | Perez-Padilla R, Menezes A. Chronic Obstructive Pulmonary Disease in Latin America. Ann Glob Health. 2019; 85(1): 7. | eng |
| dcterms.references | Ciapponi A, Alison L, Agustina M, Demian G, Silvana C, Edgardo S. The epidemiology and burden of COPD in Latin American and the Caribbean: Systematic Review and Meta-Analysis. Journal of Chronic Obstructive Pulmonary Disease. 2014; 12: 1-12. | eng |
| dcterms.references | Ministerio de Salud y Protección Social. Enfermedad Pulmonar Obstructiva Crónica – EPOC. Dirección de Promoción y Prevención. Subdirección de enfermedades no transmisibles Bogotá. 2013. | eng |
| dcterms.references | Patel J, Coutinho A, Lunacsek O, Dalal A. COPD affects worker productivity and health care costs. Int J Chron Obstruct Pulmon Dis. 2018; 13(1): 2301-11. | eng |
| dcterms.references | Chapel J, Ritchey M, Zhang D, Wang G. Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries. Am J Prev Med. 2017; 53(6S2): S143-S154. | eng |
| dcterms.references | Vinaccia S, Quiceno J. Calidad de Vida Relacionada con la Salud y Factores Psicológicos: Un Estudio desde la Enfermedad Pulmonar Obstructiva Crónica – EPOC. Terapia Psicológica. 2011; 29(1): 65-75. | spa |
| dcterms.references | Cappa V, Marcon A, Di Gennaro G, Chamitava L, Cazzoletti L, Bombieri C, et al. Health-related quality of life varies in different respiratory disorders: a multi-case control population-based study. BMC Pulm Med. 2019; 19(1):32. | eng |
| dcterms.references | McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015; 10(2):CD003793. | eng |
| dcterms.references | McDonald CF. ACP Journal Club. Review: Pulmonary rehabilitation improves health-related QoL and exercise capacity more than usual care in COPD. Ann Intern Med. 2015;162(12): JC4. | eng |
| dcterms.references | Meshe O, Claydon L, Bungay H, Andrew S. The relationship between physical activity and health status in patients with chronic obstructive pulmonary disease following pulmonary rehabilitation. Disabil Rehabil. 2017; 39(8): 746-56. | eng |
| dcterms.references | Hettle R, Wouters H, Ayres J , Gani Y, Kelly S , Lion M , Decramer M. Cost-Utility Analysis Of Tiotropium Versus Usual Care In Patients With Copd In The Uk And Belgium Respiratory. Medicine. 2012; 106: 1722-33 | eng |
| dcterms.references | García Olmos L, Alberquilla A, Ayala V, García Sagredo P, Morales L, Montserrat Carmona M, Et Al. Comorbidity In Patients With Chronic Obstructive Pulmonary Disease In Family Practice: A Cross Sectional Study. Bmc Family Practice. 2013; 14(1): 11. | eng |
| dcterms.references | Mittal R, Chhabra SK. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment. COPD. 2017;14(1):1-6. | eng |
| dcterms.references | Sidhaye V, Nishida K, Martinez F. Precision medicine in COPD: where are we and where do we need to go?. Eur Respir Rev. 2018; 27(149):180022. | eng |
| dcterms.references | Gonçalves I, Guimarães M, van Zeller M, Menezes F, Moita J, Simão P. Clinical and molecular markers in COPD. Pulmonology. 2018; 24(4): 250-9. | eng |
| dcterms.references | Crisafulli E, Pisi R, Aiello M, Vigna M, Tzani P, Torres A, et al. Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease. Respiration. 2017; 93(1): 32-41. | eng |
| dcterms.references | Singh D, Long G, Cançado JED, Higham A. Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician. Curr Opin Pulm Med. 2020; 26(2): 162-168. | eng |
| dcterms.references | Higham A, Quinn A, Cançado J, Singh D. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. 2019; 20(1): 49. | eng |
| dcterms.references | Martin C, Frija J, Burgel P. Dysfunctional lung anatomy and small airways degeneration in COPD. Int J Chron Obstruct Pulmon Dis. 2013; 8:7-13. | eng |
| dcterms.references | Balbi B, Sangiorgi C, Gnemmi I, Ferrarotti I, Vallese D, Paracchini E, et al. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1879-93. | eng |
| dcterms.references | Bradford E, Jacobson S, Varasteh J, Comellas AP, Woodruff P, O'Neal W, et al. The value of blood cytokines and chemokines in assessing COPD. Respir Res. 2017 Oct 24;18(1):180. | eng |
| dcterms.references | Riley C, Sciurba F. Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review. JAMA. 2019; 321(8): 786-797. | eng |
| dcterms.references | Dubé BP, Vermeulen F, Laveneziana P. Exertional Dyspnoea in Chronic Respiratory Diseases: From Physiology to Clinical Application. Disnea de esfuerzo en las enfermedades respiratorias crónicas: de la fisiología a la aplicación clínica. Arch Bronconeumol. 2017; 53(2): 62-70. | eng |
| dcterms.references | Rebolledo-Cobos R, Teixeira B, Correa C. Asthma, physical exercise and oxidative stress: a review of literature. 2014; 36(1): 40-8. | eng |
| dcterms.references | Ijiri N, Kanazawa H, Yoshikawa T, Hirata K. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014; 9:1235-40. | eng |
| dcterms.references | Leung J, Sin D. Asthma-COPD overlap syndrome: pathogenesis, clinical features, and therapeutic targets. BMJ. 2017; 358: j3772. | eng |
| dcterms.references | Vermylen J, Szmuilowicz E, Kalhan R. Palliative care in COPD: an unmet area for quality improvement. Int J Chron Obstruct Pulmon Dis. 2015; 10:1543-51. | eng |
| dcterms.references | Waters A. How do you assess quality of life? Vet Rec. 2018;183(22):671. | eng |
| dcterms.references | Braido F, Baiardini I, Cazzola M, Brusselle G, Marugo F, Canonica GW. Long-acting bronchodilators improve health related quality of life in patients with COPD. Respir Med. 2013;107(10):1465-1480. | eng |
| dcterms.references | Brien S, Stuart B, Dickens A, Kendrick T, Jordan R, Adab P, Thomas M. Independent determinants of disease-related quality of life in COPD - scope for nonpharmacologic interventions? Int J Chron Obstruct Pulmon Dis. 2018; 13: 247-56. | eng |
| dcterms.references | Esquinas C, Ramon M, Nuñez A, Molina J, Quintano J, Roman-Rodríguez M, Naberan K, et al. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Qual Life Res. 2020; 29(3): 607-17. | eng |
| dcterms.references | Calzetta L, Matera M, Braido F, Contoli M, Corsico A, Di Marco F, et al. Withdrawal of inhaled corticosteroids in COPD: A meta-analysis. Pulm Pharmacol Ther. 2017; 45: 148-58. | eng |
| dcterms.references | Rugbjerg M, Iepsen U, Jørgensen K, Lange P. Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses. Int J Chron Obstruct Pulmon Dis. 2015; 10: 791-801. | eng |
| dcterms.references | Bellou V, Belbasis L, Konstantinidis A, Tzoulaki I, Evangelou E. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019; 367: l5358. | eng |
| dcterms.references | Bringsvor H, Langeland E, Oftedal B, Skaug K, Assmus J, Bentsen S. Self-management and health related quality of life in persons with chronic obstructive pulmonary disease. Qual Life Res. 2019; 28(11): 2889-99. | eng |
| dcterms.references | Tiemensma J, Gaab E, Voorhaar M, Asijee G, Kaptein A. Illness perceptions and coping determine quality of life in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016; 11: 2001-7. | eng |
| dcterms.references | Weldam S, Lammers J, Heijmans M, Schuurmans M. Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions. BMC Fam Pract. 2014; 15:140. | eng |
| dcterms.references | Cannon D, Sriram K, Liew A, Sun J. Resilience Factors Important in Health-Related Quality of Life of Subjects With COPD. Respir Care. 2018; 63(10): 1281-92. | eng |
| dcterms.references | Benzo R, Vickers K, Novotny P, Tucker S, Hoult J, Neuenfeldt P, et al. Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study. Am J Respir Crit Care Med. 2016; 194(6): 672-80. | eng |
| dcterms.references | Tupper O, Gregersen T, Ringbaek T, Brøndum E, Frausing E, Green A, Ulrik CS. Effect of tele-health care on quality of life in patients with severe COPD: a randomized clinical trial. Int J Chron Obstruct Pulmon Dis. 2018; 13: 2657. | eng |
| dcterms.references | Vianello A, Fusello M, Gubian L, Rinaldo C, Dario C, Concas A, et al. Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med. 2016; 16(1):157. | eng |
| dcterms.references | Stamenova V, Liang K, Yang R, Engel K, van Lieshout F, Lalingo E, et al. Technology-Enabled Self-Management of Chronic Obstructive Pulmonary Disease With or Without Asynchronous Remote Monitoring: Randomized Controlled Trial. J Med Internet Res. 2020; 22(7):e18598. | eng |
| dcterms.references | Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim S, Saunders J, et al. Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial. JAMA. 2019; 322(14): 1371-80. | eng |
| dcterms.references | Ringbæk T, Green A, Laursen L, Frausing E, Brøndum E, Ulrik C. Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial. Int J Chron Obstruct Pulmon Dis. 2015; 10: 1801-8. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | eng |
| sb.programa | Especialización en Rehabilitación Cardiopulmonar y Vascular | spa |
| sb.sede | Sede Barranquilla | spa |